Enzymatica AB (publ)

DB:EN9 Stock Report

Market Cap: €62.1m

Enzymatica Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Sana Alajmovic

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenure9.3yrs

Recent management updates

Recent updates

CEO

Sana Alajmovic

less than a year
Tenure

Ms. Sana Alajmovic Co-Founded Sigrid Therapeutics AB and served as its Chief Executive Officer until February 1, 2026. She serves as Chief Executive Officer at Enzymatica AB (publ) since February 1, 2026....

Leadership Team

NamePositionTenureCompensationOwnership
Sana Alajmovic
Chief Executive Officerless than a yearno datano data
Holger Lembrer
Chief Financial Officerno datano datano data
Anja Tragardh
Communications Manager1.6yrsno datano data
Anna Soderlund
Senior Director of Marketing & Sales2.3yrsno data0.0082%
€ 5.1k
0.9yrs
Average Tenure
47yo
Average Age

Experienced Management: EN9's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Bengt Baron
Independent Chairman9.3yrsSEK 500.00k0.0082%
€ 5.1k
Mats Andersson
Director9.3yrsSEK 225.00kno data
Louise Nicolin
Independent Director9.3yrsSEK 275.00k0.11%
€ 70.8k
Gudmundur Palmason
Independent Director10.2yrsSEK 225.00kno data
Helene Willberg
Independent Director4.9yrsSEK 400.00k0.82%
€ 509.6k
Moa Fransson
Independent Director4yrsSEK 225.00k0.0056%
€ 3.5k
9.3yrs
Average Tenure
57.5yo
Average Age

Experienced Board: EN9's board of directors are considered experienced (9.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/20 11:11
End of Day Share Price 2026/04/17 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Enzymatica AB (publ) is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jakob LembkeABG Sundal Collier Sponsored
Gustaf MeyerRedeye